Which company offers more value? Imprimis Pharmaceuticals, Inc. (NASDAQ:IMMY), e.l.f. Beauty, Inc. (NYSE:ELF)

Imprimis Pharmaceuticals, Inc. (NASDAQ:IMMY)

Imprimis Pharmaceuticals, Inc. (NASDAQ:IMMY) Performance Snapshot

Imprimis Pharmaceuticals, Inc. (NASDAQ:IMMY) Price Insight

e.l.f. Beauty, Inc. (NYSE:ELF)

e.l.f. Beauty, Inc. (NYSE:ELF), closed the last trading session at $17.76 with decrease of $-0.359999999999999 or -1.99 percent against the opening price of $18.12. The trading day volume of the company stands at 539479 shares while the average trading volume of e.l.f. Beauty, Inc. (NYSE:ELF) is 750.81 Million over the course of 3 consecutive months. Which signifies a pretty good change over the time with its shares outstanding of 48.93 Million.

The price target of e.l.f. Beauty, Inc. (NYSE:ELF) is currently set at 23.78 by the analysts. The stock is $-15.51 Below its 1-Year High which is $21.02. ELF hit its 1-Year low price of $7.58. The company is currently rated by analyst who are keeping a close eye on the stock as 2.1. Where 1 means Buy, 2.5 meaning Hold and 5 as Sell.

Performance Indicators of e.l.f. Beauty, Inc. (NYSE:ELF)

The value of the stock decreased by -4.31% during the previous week performance. Looking at the 1 month performance of e.l.f. Beauty, Inc. (NYSE:ELF), the stock dipped -11.99%. While the 1 year performance shows a positive percentage of 12.98 and year to date performance stands at 10.11%.

e.l.f. Beauty, Inc. (NYSE:ELF) Analytical Review

The stock needs to grow about $6.02 to reach its price target. In order to seek the stock’s directional movements, 20-Days, 50 Days and 200-Days moving averages are -6.82%, -7% and 11.65 percent respectively. The stock trades about 6.86 percent of its Float giving its total shares Outstanding are 48.93 Million. ELF gained about 108.94 percent in 6 months showing its Average True Range of 0.77. The company currently has a RSI and Beta of 37.79 and 2.18.

While talking about e.l.f. Beauty, Inc. (NYSE:ELF) valuation ratios, the stock trades with a P/S and P/B of 3.26 and 3.5 which is significantly better and attractive as compared to its peers.